title: [Community-acquired methicillin-resistant Staphylococcus aureus: Review].
abstract: Community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) have emerged worldwide. These CA-MRSA are different from classical hospital-acquired MRSA. They share common characteristics: they affect mainly young subjects, without past medical history. The majority of strains produce the Panton-Valentine leukocidin. They are mainly responsible for suppurative skin infections and rarely for invasive infections such as necrotizing pneumonia. The situation in the US is alarming with a main circulating clone the USA300 clone, whereas in Europe, the diffusion of CA-MRSA strains remains limited. It is important to take advantage of the experience acquired from the US to limit the potential spread of such CA-MRSA strains.
authors.affiliation: Hôpital Bonnet, Infectious Diseases and Dermatology Unit, Fréjus, France. del-giudice-p@chi-frejus-saint-raphael.fr
authors.forename: Pascal
authors.initials: P
authors.lastname: Del Giudice
authors.forename: Pierre
authors.initials: P
authors.lastname: Tattevin
authors.forename: Jérôme
authors.initials: J
authors.lastname: Etienne
mesh_terms: D017714:Community-Acquired Infections / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology / Q000628:therapy; D005060:Europe / Q000453:epidemiology; D005602:France / Q000453:epidemiology; D006801:Humans; D016106:Methicillin Resistance / Q000235:genetics / Q000502:physiology; D055624:Methicillin-Resistant Staphylococcus aureus / Q000235:genetics / Q000378:metabolism / Q000472:pathogenicity / Q000502:physiology*; D013203:Staphylococcal Infections / Q000453:epidemiology* / Q000382:microbiology / Q000628:therapy; D014481:United States / Q000453:epidemiology; D037521:Virulence Factors / Q000235:genetics
chemical_list: D037521:Virulence Factors